BRIEF published on 09/30/2024 at 19:05, 1 month 20 days ago Avemio AG Publishes Half-Year Report 2024 Media Technology Half-year Report Avemio AG Corporate Strategy 2024 Financial Results
PRESS RELEASE published on 09/30/2024 at 19:00, 1 month 20 days ago Avemio AG publishes half-year report 2024 Avemio AG reports financial results for the first half of 2024, highlighting revenue challenges and strategic measures for growth amidst industry-specific issues Growth Strategy Financial Results Half-year Report Avemio AG Revenue Challenges
BRIEF published on 07/26/2024 at 14:09, 3 months 26 days ago Avemio AG Strengthens Buy-and-Build Strategy through Acquisition Acquisition Avemio AG Corporate Finance Equity Buy-and-Build
BRIEF published on 07/26/2024 at 14:06, 3 months 26 days ago Avemio AG Acquires 80% Stake in L.E.A Investment GmbH Acquisition Investment Avemio AG Corporate Finance L.E.A. Investment GmbH
PRESS RELEASE published on 07/26/2024 at 14:04, 3 months 26 days ago Avemio AG strengthens buy-and-build strategy through acquisition of Corporate Finance Boutique Avemio AG strengthens buy-and-build strategy through acquisition of Corporate Finance Boutique, expanding expertise in financing and M&A activities. Andreas Fischer to lead LEA Group Acquisition Avemio AG Corporate Finance Buy-and-build Strategy Andreas Fischer
PRESS RELEASE published on 07/26/2024 at 14:01, 3 months 26 days ago EQS-Adhoc: Avemio AG: Acquisition of an 80% stake in L.E.A Investment GmbH and its subsidiary Infinment GmbH Avemio AG acquires 80% stake in L.E.A Investment GmbH and Infinment GmbH. Transaction expected to close by 31 August 2024. Purchase price in mid-single-digit million Euro range Acquisition Avemio AG Share Transfer L.E.A Investment GmbH Infinment GmbH
BRIEF published on 07/15/2024 at 10:07, 4 months 6 days ago Avemio AG: Strategic Shift and Profit Margin Improvement Expected Media Technology EBITDA Avemio AG BUY Rating GBC AG
PRESS RELEASE published on 07/15/2024 at 10:02, 4 months 6 days ago Original-Research: Avemio AG (von GBC AG): BUY Avemio AG reported sales of €99.15 million for 2023 with an expected increase in profit margins. Strategic focus on media technology segment for customer loyalty and earnings quality improvement Media Technology Sales Growth Avemio AG Strategic Focus Profit Margins
BRIEF published on 06/28/2024 at 16:35, 4 months 22 days ago Avemio AG Publishes Audited Figures for 2023, Confirming Preliminary Results EBITDA Revenue 2023 Financial Year Avemio AG Annual Results
PRESS RELEASE published on 06/28/2024 at 16:30, 4 months 22 days ago Avemio AG published audited consolidated figures for 2023 – preliminary results confirmed Avemio AG releases audited 2023 annual report confirming preliminary results. Company reports stable revenue and break-even earnings EBITDA Revenue Avemio AG 2023 Annual Report Audited Consolidated Figures
Published on 11/21/2024 at 14:15, 18 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 33 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 33 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 33 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 17 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 18 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 58 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 35 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 13 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
